Cargando…

Assessment of HIF-1α expression and release following endothelial injury in-vitro and in-vivo

BACKGROUND: Endothelial injury is an early and enduring feature of cardiovascular disease. Inflammation and hypoxia may be responsible for this, and are often associated with the up-regulation of several transcriptional factors that include Hypoxia Inducible Factor-1 (HIF-1). Although it has been re...

Descripción completa

Detalles Bibliográficos
Autores principales: Heikal, Lamia, Ghezzi, Pietro, Mengozzi, Manuela, Ferns, Gordon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6016879/
https://www.ncbi.nlm.nih.gov/pubmed/30134815
http://dx.doi.org/10.1186/s10020-018-0026-5
_version_ 1783334622624481280
author Heikal, Lamia
Ghezzi, Pietro
Mengozzi, Manuela
Ferns, Gordon
author_facet Heikal, Lamia
Ghezzi, Pietro
Mengozzi, Manuela
Ferns, Gordon
author_sort Heikal, Lamia
collection PubMed
description BACKGROUND: Endothelial injury is an early and enduring feature of cardiovascular disease. Inflammation and hypoxia may be responsible for this, and are often associated with the up-regulation of several transcriptional factors that include Hypoxia Inducible Factor-1 (HIF-1). Although it has been reported that HIF-1α is detectable in plasma, it is known to be unstable. Our aim was to optimize an assay for HIF-1α to be applied to in vitro and in vivo applications, and to use this assay to assess the release kinetics of HIF-1α following endothelial injury. METHODS: An ELISA for the measurement of HIF-1α in cell-culture medium and plasma was optimized, and the assay was used to determine the best conditions for sample collection and storage. The results of the ELISA were validated using Western blotting and immunohistochemistry (IHC). In vitro, a standardized injury was produced in a monolayer of rat aortic endothelial cells (RAECs) and intracellular HIF-1α was measured at intervals over 24 h. In vivo, a rat angioplasty model was used. The right carotid artery was injured using a 2F Fogarty balloon catheter. HIF-1α was measured in the plasma and in the arterial tissue (0, 1, 2, 3 and 5 days post injury). RESULTS: The HIF-1α ELISA had a limit of detection of 2.7 pg/mL and was linear up to 1000 pg/ mL. Between and within-assay, the coefficient of variation values were less than 15%. HIF-1α was unstable in cell lysates and plasma, and it was necessary to add a protease inhibitor immediately after collection, and to store samples at -80 °C prior to analysis. The dynamics of HIF-1α release were different for the in vitro and in vivo models. In vitro, HIF-1α reached maximum concentrations approximately 2 h post injury, whereas peak values in plasma and tissues occurred approximately 2 days post injury, in the balloon injury model. CONCLUSION: HIF-1α can be measured in plasma, but this requires careful sample collection and storage. The carotid artery balloon injury model is associated with the transient release of HIF-1α into the circulation that probably reflects the hypoxia induced in the artery wall. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s10020-018-0026-5) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6016879
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-60168792018-07-05 Assessment of HIF-1α expression and release following endothelial injury in-vitro and in-vivo Heikal, Lamia Ghezzi, Pietro Mengozzi, Manuela Ferns, Gordon Mol Med Research Article BACKGROUND: Endothelial injury is an early and enduring feature of cardiovascular disease. Inflammation and hypoxia may be responsible for this, and are often associated with the up-regulation of several transcriptional factors that include Hypoxia Inducible Factor-1 (HIF-1). Although it has been reported that HIF-1α is detectable in plasma, it is known to be unstable. Our aim was to optimize an assay for HIF-1α to be applied to in vitro and in vivo applications, and to use this assay to assess the release kinetics of HIF-1α following endothelial injury. METHODS: An ELISA for the measurement of HIF-1α in cell-culture medium and plasma was optimized, and the assay was used to determine the best conditions for sample collection and storage. The results of the ELISA were validated using Western blotting and immunohistochemistry (IHC). In vitro, a standardized injury was produced in a monolayer of rat aortic endothelial cells (RAECs) and intracellular HIF-1α was measured at intervals over 24 h. In vivo, a rat angioplasty model was used. The right carotid artery was injured using a 2F Fogarty balloon catheter. HIF-1α was measured in the plasma and in the arterial tissue (0, 1, 2, 3 and 5 days post injury). RESULTS: The HIF-1α ELISA had a limit of detection of 2.7 pg/mL and was linear up to 1000 pg/ mL. Between and within-assay, the coefficient of variation values were less than 15%. HIF-1α was unstable in cell lysates and plasma, and it was necessary to add a protease inhibitor immediately after collection, and to store samples at -80 °C prior to analysis. The dynamics of HIF-1α release were different for the in vitro and in vivo models. In vitro, HIF-1α reached maximum concentrations approximately 2 h post injury, whereas peak values in plasma and tissues occurred approximately 2 days post injury, in the balloon injury model. CONCLUSION: HIF-1α can be measured in plasma, but this requires careful sample collection and storage. The carotid artery balloon injury model is associated with the transient release of HIF-1α into the circulation that probably reflects the hypoxia induced in the artery wall. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s10020-018-0026-5) contains supplementary material, which is available to authorized users. BioMed Central 2018-05-16 /pmc/articles/PMC6016879/ /pubmed/30134815 http://dx.doi.org/10.1186/s10020-018-0026-5 Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Heikal, Lamia
Ghezzi, Pietro
Mengozzi, Manuela
Ferns, Gordon
Assessment of HIF-1α expression and release following endothelial injury in-vitro and in-vivo
title Assessment of HIF-1α expression and release following endothelial injury in-vitro and in-vivo
title_full Assessment of HIF-1α expression and release following endothelial injury in-vitro and in-vivo
title_fullStr Assessment of HIF-1α expression and release following endothelial injury in-vitro and in-vivo
title_full_unstemmed Assessment of HIF-1α expression and release following endothelial injury in-vitro and in-vivo
title_short Assessment of HIF-1α expression and release following endothelial injury in-vitro and in-vivo
title_sort assessment of hif-1α expression and release following endothelial injury in-vitro and in-vivo
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6016879/
https://www.ncbi.nlm.nih.gov/pubmed/30134815
http://dx.doi.org/10.1186/s10020-018-0026-5
work_keys_str_mv AT heikallamia assessmentofhif1aexpressionandreleasefollowingendothelialinjuryinvitroandinvivo
AT ghezzipietro assessmentofhif1aexpressionandreleasefollowingendothelialinjuryinvitroandinvivo
AT mengozzimanuela assessmentofhif1aexpressionandreleasefollowingendothelialinjuryinvitroandinvivo
AT fernsgordon assessmentofhif1aexpressionandreleasefollowingendothelialinjuryinvitroandinvivo